AX-8 - Axalbion
Randomized Proof-of-concept Study of AX-8, a TRPM8 Agonist, in Refractory or Unexplained Chronic Cough (ATS 2023) - Mar 25, 2023 - Abstract #A2532; Pres time: May 21, 2023; 03:03 PM - 03:15 PM; Location: Marriott Marquis Washington, Independence Ballroom Salons A-D (Level M4); "This data suggests TRPM8 agonism shows potential for control of RCC/UCC as an alternative or adjunct to other therapies, especially in those patients complaining of cough driven by throat sensations." 
Clinical • Chronic Cough • Cough • Pulmonary Disease • Respiratory Diseases
https://www.abstractsonline.com/pp8/#!/10703/presentation/8269
 
J. Smith1; J. Hull2; S. S. Birring3; A. H. Morice4; S. Parker5; P. A. Marsden6; I. D. Pavord7; L. Mcgarvey8; H. Fowles9; A. Turner10; O. Piorot11; M. Kitt12
 
Mar 25, 2023
 
Prev Next